自然堂赴港IPO：家族持股超八成，过度依赖单一品牌

Group 1 - The core point of the article is that Jala Group, known for its brand Naturals, is facing significant challenges despite its upcoming IPO, including weak performance, low profit margins, and heavy reliance on marketing over research and development [1][11][12] - Jala Group's revenue growth has been sluggish, with projected revenues of 42.92 billion, 44.42 billion, and 46.01 billion from 2022 to 2024, reflecting an average annual growth rate of only about 3.5%, significantly lower than the overall growth rate of the domestic beauty industry [4][5][7] - The company's net profit margins are low, with figures of 3.24%, 6.80%, and 4.13% from 2022 to 2024, and only reaching 7.81% in the first half of 2025, indicating operational inefficiencies and cost structure issues [7][8][9] Group 2 - Jala Group has heavily invested in marketing, with sales and marketing expenses reaching 24.45 billion, 24.06 billion, and 27.16 billion from 2022 to 2024, accounting for over 54% of annual revenue, yet this has not translated into significant revenue growth [8][9][10] - The company's research and development spending has decreased, with R&D expenses dropping from 1.2 billion in 2022 to only 0.4 billion in the first half of 2025, resulting in a declining R&D expense ratio from 2.8% to 1.7%, which is well below the 3%-5% standard of international beauty giants [9][10][11] - Jala Group's over-reliance on its core brand Naturals is evident, with revenue contributions from this brand accounting for 94.6%, 95.9%, and 95.4% from 2022 to 2024, indicating a lack of effective growth from its other brands [10][11][12] Group 3 - The company is struggling to transition to a high-end market, with attempts to launch premium products failing to resonate with consumers, as evidenced by poor sales of its high-priced Gold Diamond Micro-sculpting series [11][12][13] - Jala Group's governance structure raises concerns, as the founding family's control over 87% of voting rights may hinder strategic flexibility and professional decision-making, especially in an industry that increasingly values scientific research and data-driven approaches [12][13][14] - The upcoming IPO represents a significant milestone for Jala Group, but achieving a true high-end brand status requires overcoming challenges related to brand dependency, marketing-heavy strategies, and governance issues [13][14]